Empowering biopharma with unified epidemiology,
incidence and prevalence data alongside claims-based population
insights, for precise market sizing and patient population
analysis
LONDON, May 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:
CLVT), a leading global provider of transformative intelligence,
today announced the launch of Epidemiology Intelligence™. The new
solution combines rich insights from epidemiology, incidence and
prevalence database solutions. It includes U.S. claims-based
population insights to empower biopharma companies to
accurately gauge market size and target patient demographics with
ease.
In today's rapidly evolving market landscape, precise
forecasting is essential for biopharmaceutical companies. Yet,
traditional research methods often come with limitations that can
lead to inaccurate estimations and costly consequences.
Epidemiology Intelligence empowers users with unique insights to
address critical questions about the drug-treatable population. The
solution facilitates precise assessments, identification of niche
populations and accurate predictions based on population
insights.
Ravindra Sharma, VP Product
Management, Clarivate, said: "The launch of Epidemiology
Intelligence marks a significant milestone for Clarivate in our
ongoing commitment to deliver comprehensive and actionable
solutions to life sciences and healthcare companies. Clients can
now access comprehensive coverage of disease epidemiology paired
with expert analysis, seamlessly integrated into a unified
platform. The new solution enables them to deliver safe, effective
and commercially successful treatments to patients faster."
Epidemiology Intelligence accelerates data-driven
decision-making across the drug development lifecycle. Clients can
benchmark market forecasts, validate investments, pinpoint growth
opportunities and utilize the solution to strategically position
their products for success.
To learn more about Epidemiology Intelligence, visit here.
About Epidemiology Intelligence
Epidemiology Intelligence is a new, unified Clarivate patient
population offering that brings together our legacy Epidemiology
and Incidence and Prevalence Database solutions, as well as
claims-based population insights, on a single platform. This
transformative solution offers user-friendly visualizations, easy
data exports and a unique breadth and depth of patient population
insights. Conduct thorough market assessment with comprehensive
coverage across 1200+ diseases and procedures. Dive deep into
expert disease-specific epidemiology analysis and 10 and 20-year
forecasts across 220 indications and over 5000 patient populations.
Leverage expanded patient segmentation and location granularity
with insights sourced from Clarivate U.S. Real-World Data.
About Clarivate
Clarivate™ is a leading global provider of transformative
intelligence. We offer enriched data, insights & analytics,
workflow solutions and expert services in the areas of Academia
& Government, Intellectual Property and Life Sciences &
Healthcare. For more information, please
visit www.clarivate.com
Media Contact:
Catherine
Daniel
Director External Communications, Life Sciences &
Healthcare
newsroom@clarivate.com
Logo -
https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/clarivate-introduces-epidemiology-intelligence-for-precision-patient-population-analysis-302136896.html